Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1990;68(Suppl):191–196.

Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.

G Del Giudice 1, P H Lambert 1, K Mendis 1, A Pessi 1, M Tanner 1
PMCID: PMC2393021  PMID: 2094587

Abstract

Availability of synthetic and recombinant peptides reproducing the repetitive regions of the circumsporozoite (CS) proteins of Plasmodium falciparum and P. vivax has allowed the development of assays for the detection of specific antibodies and of potential subunit vaccines. Knowledge of the immune responses to malaria sporozoites is a prerequisite for the optimal design of a sporozoite antigen-based vaccine. Studies carried out in areas with stable P. falciparum malaria (United Republic of Tanzania) have shown that antibodies against the synthetic peptide (NANP)40 increase as a function of age. Cluster analysis revealed marked inter-household variation of the anti-sporozoite antibody response, despite comparable risks of exposure to infectious bites. An age-related prevalence of anti-P. vivax sporozoite antibodies has been observed in an area of Sri Lanka with unstable malaria, using a 45-mer synthetic peptide reproducing a defined sequential array of the two main 9-mer variants of the P. vivax CS protein. In this area, anti-(NANP)40 antibodies became detectable after the first epidemic of P. falciparum malaria. Interestingly, their prevalence also increased with age. Since this population had not been exposed to P. falciparum malaria for at least 10 years previously, one can suggest that anti-sporozoite antibodies reflect the relative exposure to infectious bites in the different age groups, and, in turn, the transmission of the disease. This can be particularly useful in areas where entomological indices of transmission tend to be unreliable because of the low vectorial capacity and wide fluctuations in vector densities.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnot D. E., Barnwell J. W., Stewart M. J. Does biased gene conversion influence polymorphism in the circumsporozoite protein-encoding gene of Plasmodium vivax? Proc Natl Acad Sci U S A. 1988 Nov;85(21):8102–8106. doi: 10.1073/pnas.85.21.8102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ballou W. R., Hoffman S. L., Sherwood J. A., Hollingdale M. R., Neva F. A., Hockmeyer W. T., Gordon D. M., Schneider I., Wirtz R. A., Young J. F. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet. 1987 Jun 6;1(8545):1277–1281. doi: 10.1016/s0140-6736(87)90540-x. [DOI] [PubMed] [Google Scholar]
  3. Campbell G. H., Brandling-Bennett A. D., Roberts J. M., Collins F. H., Kaseje D. C., Barber A. M., Turner A. Detection of antibodies in human sera to the repeating epitope of the circumsporozoite protein of Plasmodium falciparum using the synthetic peptide (NANP)3 in an enzyme-linked immunosorbent assay (ELISA). Am J Trop Med Hyg. 1987 Jul;37(1):17–21. doi: 10.4269/ajtmh.1987.37.17. [DOI] [PubMed] [Google Scholar]
  4. Chizzolini C., Dupont A., Akue J. P., Kaufmann M. H., Verdini A. S., Pessi A., Del Giudice G. Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon. Am J Trop Med Hyg. 1988 Aug;39(2):150–156. doi: 10.4269/ajtmh.1988.39.150. [DOI] [PubMed] [Google Scholar]
  5. Del Giudice G., Cheng Q., Mazier D., Berbiguier N., Cooper J. A., Engers H. D., Chizzolini C., Verdini A. S., Bonelli F., Pessi A. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice. Immunology. 1988 Feb;63(2):187–191. [PMC free article] [PubMed] [Google Scholar]
  6. Del Giudice G., Engers H. D., Tougne C., Biro S. S., Weiss N., Verdini A. S., Pessi A., Degremont A. A., Freyvogel T. A., Lambert P. H. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children. Am J Trop Med Hyg. 1987 Mar;36(2):203–212. doi: 10.4269/ajtmh.1987.36.203. [DOI] [PubMed] [Google Scholar]
  7. Del Giudice G., Verdini A. S., Pinori M., Pessi A., Verhave J. P., Tougne C., Ivanoff B., Lambert P. H., Engers H. D. Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides. J Clin Microbiol. 1987 Jan;25(1):91–96. doi: 10.1128/jcm.25.1.91-96.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Esposito F., Lombardi S., Modiano D., Zavala F., Reeme J., Lamizana L., Coluzzi M., Nussenzweig R. S. Prevalence and levels of antibodies to the circumsporozoite protein of Plasmodium falciparum in an endemic area and their relationship to resistance against malaria infection. Trans R Soc Trop Med Hyg. 1988;82(6):827–832. doi: 10.1016/0035-9203(88)90007-7. [DOI] [PubMed] [Google Scholar]
  9. Herrington D. A., Clyde D. F., Losonsky G., Cortesia M., Murphy J. R., Davis J., Baqar S., Felix A. M., Heimer E. P., Gillessen D. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature. 1987 Jul 16;328(6127):257–259. doi: 10.1038/328257a0. [DOI] [PubMed] [Google Scholar]
  10. Hoffman S. L., Oster C. N., Plowe C. V., Woollett G. R., Beier J. C., Chulay J. D., Wirtz R. A., Hollingdale M. R., Mugambi M. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Science. 1987 Aug 7;237(4815):639–642. doi: 10.1126/science.3299709. [DOI] [PubMed] [Google Scholar]
  11. Hoffman S. L., Wistar R., Jr, Ballou W. R., Hollingdale M. R., Wirtz R. A., Schneider I., Marwoto H. A., Hockmeyer W. T. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. N Engl J Med. 1986 Sep 4;315(10):601–606. doi: 10.1056/NEJM198609043151001. [DOI] [PubMed] [Google Scholar]
  12. Nardin E. H., Nussenzweig R. S., McGregor I. A., Bryan J. H. Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science. 1979 Nov 2;206(4418):597–599. doi: 10.1126/science.386511. [DOI] [PubMed] [Google Scholar]
  13. Sharma S., Gwadz R. W., Schlesinger D. H., Godson G. N. Immunogenicity of the repetitive and nonrepetitive peptide regions of the divergent CS protein of Plasmodium knowlesi. J Immunol. 1986 Jul 1;137(1):357–361. [PubMed] [Google Scholar]
  14. Smith P. G., Pike M. C. Generalisations of two tests for the detection of household aggregation of disease. Biometrics. 1976 Dec;32(4):817–828. [PubMed] [Google Scholar]
  15. Tanner M., Degrémont A., de Savigny D., Freyvogel T. A., Mayombana C., Tayari S. Longitudinal study on the health status of children in Kikwawila village, Tanzania: study area and design. Acta Trop. 1987 Jun;44(2):119–136. [PubMed] [Google Scholar]
  16. Vergara U., Gwadz R., Schlesinger D., Nussenzweig V., Ferreira A. Multiple non-repeated epitopes on the circumsporozoite protein of Plasmodium knowlesi. Mol Biochem Parasitol. 1985 Mar;14(3):283–292. doi: 10.1016/0166-6851(85)90056-8. [DOI] [PubMed] [Google Scholar]
  17. Zavala F., Tam J. P., Masuda A. Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites. J Immunol Methods. 1986 Oct 23;93(1):55–61. doi: 10.1016/0022-1759(86)90432-1. [DOI] [PubMed] [Google Scholar]
  18. de la Cruz V. F., Lal A. A., McCutchan T. F. Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development. J Biol Chem. 1987 Sep 5;262(25):11935–11939. [PubMed] [Google Scholar]
  19. de la Cruz V. F., Lal A. A., Welsh J. A., McCutchan T. F. Evolution of the immunodominant domain of the circumsporozoite protein gene from Plasmodium vivax. Implications for vaccines. J Biol Chem. 1987 May 15;262(14):6464–6467. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES